An Act To Require Insurance Coverage For Glucagon-Like Peptide-1 Receptor Agonist Medication

This bill requires Maine health insurance companies to cover FDA-approved GLP-1 receptor agonist medications prescribed by a doctor, with out-of-pocket costs limited to $35 per 30-day prescription. It prohibits insurers from requiring prior authorization for this coverage and mandates an education campaign by the state insurance department about the medication and its health benefits. The requirements apply to all health plans issued or renewed on or after January 1, 2026. This directly affects patients prescribed these medications and insurers offering health plans in Maine.